Literature DB >> 18513527

Prognostic value of preoperative indexed end-systolic left ventricle diameter in the outcome after surgery in patients with chronic aortic regurgitation.

Antonia Sambola1, Pilar Tornos, Ignacio Ferreira-Gonzalez, Artur Evangelista.   

Abstract

BACKGROUND: End-systolic diameter (ESD) is an important parameter in the prognosis and indication for surgery in chronic aortic regurgitation (AR). It has been suggested that ESD values noncorrected for body surface area (BSA) could be inappropriate in the management of patients with extreme BSA. The aim of the study was to assess the usefulness of indexed ESD (IESD) of the left ventricle in the management of patients with severe isolated chronic AR.
METHODS: One hundred forty-seven patients underwent surgery for chronic AR and were followed up for a mean of 8 +/- 6 years (1-22 years). A post hoc assessment was made of the prognostic value of preoperative ESD and IESD in different BSA percentiles: group 1, <or= 25th percentile (BSA 1.43-1.68 m(2), n = 40); group 2, >25th percentile and <or=75th percentile (BSA 1.69-1.91 m(2), n = 68); and group 3, >75th percentile (BSA 1.92-2.24 m(2), n = 39).
RESULTS: Age-adjusted preoperative ESD and IESD were independent predictors of mortality or heart failure in the entire population. Magnitude of the relative risk was slightly greater using preoperative IESD than ESD (HR 1.07, 95% CI 1.01-1.29, P = .017; HR 1.04, 95% CI 1.01-1.08, P = .016). In group 1, the age-adjusted expected mortality rate would drop if IESD of 25 mm/m(2) was used as a surgical criterion instead of ESD 50 mm, from 37.94% to 24.27% at 10 years (P = .002).
CONCLUSIONS: The use of IESD improves the prediction of unfavorable outcomes after surgery in patients with low BSA but not in those with high BSA. In patients with low BSA, IESD >or=25 mm/m(2) should be used as a cutoff point for surgery rather than ESD >50 mm.

Entities:  

Mesh:

Year:  2008        PMID: 18513527     DOI: 10.1016/j.ahj.2007.12.025

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  8 in total

Review 1.  Aneurysms of the ascending aorta.

Authors:  Daniel Lavall; Hans-Joachim Schäfers; Michael Böhm; Ulrich Laufs
Journal:  Dtsch Arztebl Int       Date:  2012-03-30       Impact factor: 5.594

Review 2.  Contemporary reviews by surgeon: timing of operation for chronic aortic regurgitation.

Authors:  Kazuhiro Taniguchi; Yoshiki Sawa
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-09-26

3.  Long term results and predictors of left ventricular function recovery after aortic valve replacement for chronic aortic regurgitation.

Authors:  Hiroyuki Saisho; Koichi Arinaga; Satoshi Kikusaki; Yuichiro Hirata; Kumiko Wada; Tatsuyuki Kakuma; Hiroyuki Tanaka
Journal:  Ann Thorac Cardiovasc Surg       Date:  2015-02-16       Impact factor: 1.520

Review 4.  Timing of Surgical Intervention for Aortic Regurgitation.

Authors:  Brett Hiendlmayr; Joseph Nakda; Ossama Elsaid; Xuan Wang; Aidan Flynn
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-11

Review 5.  Timing of aortic valve intervention in pediatric chronic aortic insufficiency.

Authors:  Justin T Tretter; Alan Langsner
Journal:  Pediatr Cardiol       Date:  2014-09-02       Impact factor: 1.655

6.  Prognostic value of echocardiography with particular reference to patients with valvular heart disease.

Authors:  Wyatt Unger; Maggie Diller; Nishant Kalra; Vincent L Sorrell
Journal:  F1000 Med Rep       Date:  2009-12-15

7.  Transaortic repair of concomitant mitral insufficiency in patients with critical aortic stenosis undergoing aortic valvular replacement.

Authors:  Ufuk Çiloğlu; Mustafa Aldağ; Şebnem Albeyoğlu; Hakan Kutlu; Canan Karakaya
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2019-01-01       Impact factor: 0.332

8.  Reverse remodelling after aortic valve replacement for chronic aortic regurgitation.

Authors:  Ayumi Koga-Ikuta; Satsuki Fukushima; Naonori Kawamoto; Tetsuya Saito; Yusuke Shimahara; Shin Yajima; Naoki Tadokoro; Takashi Kakuta; Toshihiro Fukui; Tomoyuki Fujita
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-06-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.